NEW DELHI – 30 January 2016 – For the second year in a row, Medtronic hosted the Medical Device Summit in New Delhi on 30th January 2016, bringing together leading national and international healthcare practitioners, research scientists, and business leaders. The theme of this year’s Summit was “Technological Innovation,” and speakers shared their views and latest updates on innovation and clinical outcomes driving the evolution of the healthcare ecosystem. The Summit addressed some of the key issues concerning Cardiac Care in India such as the need for standard treatment guidelines, skilled practitioners, advanced infrastructure and technology as a solution for improving patient outcomes and increasing access.

In a first-of-its-kind initiative at the Summit, cardiac specialists had the opportunity to experience hands-on simulations of current and upcoming innovative therapies and technologies for the treatment of cardiovascular diseases at Innovation Village. Disease conditions examined included bradycardia (slow heart rhythm), aortic stenosis (heart valve defect), coronary artery bypass graft surgery (bypass surgery), peripheral artery disease and angioplasty in patients with diabetes.

Referring to Innovation Village, Bob White, senior vice president and president, Asia Pacific, Medtronic said, “Medtronic is committed to accelerating the development of therapy innovations for patients with chronic diseases to broaden access and improve outcomes with measurable economic value. In addition to the depth and breadth of our product portfolio, we are developing services and solutions that will help to transform healthcare. The Innovation Village created an environment conducive to group collaboration and productive exchange of ideas with the goal of taking healthcare further, together.”

Medtronic, the global leader in medical technology, designed the Innovation Village with the objective of giving clinicians a look at future technologies and products under development that can address barriers to healthcare access in India while providing technologies with strong clinical evidence.

Dr. Atul Mathur, director, Interventional Cardiology, Escorts Heart Institute and Research Center, New Delhi, who convened a workshop at the Innovation Village, said, “Opportunities that give clinicians a chance to update their knowledge through practical, hands-on exposure to new, cutting-edge technologies and products under development motivate them to manage their cases more effectively. The Innovation Village was an excellent way for us to examine up close the life-saving devices that are being used to treat cardiovascular disease around the world.”

Speaking at the Innovation Village, Shamik Dasgupta, vice president of the Cardiac and Vascular Group for Medtronic in South Asia said, “True to our Mission to alleviate pain, restore health and extend life, everything we do is consistent with delivering the best possible care for patients. For Medtronic, innovation and clinical outcomes go hand in hand and we actively work towards managing and demonstrating the outcomes by driving product quality and safety initiatives through the processes of product development, manufacturing, supplier quality assessments, clinical trials, post-market surveillance activities, and customer satisfaction surveys.”

The Innovation Village was attended by more than 250 cardiologists from different parts of the country and leading medical institutions. Dr. Jagdish Prasad, director general of Health Services, Ministry of Health and Family Welfare, was the guest of honor at the summit.

About Medtronic
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Medtronic began its operations in India in 1979. Headquartered at Solitaire Corporate Park in Mumbai, it has offices in Ahmedabad, Bengaluru, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Pune and Vadodara.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

Contacts:

Dheeman Vaidya
India Medtronic Private Limited
dheeman.vaidya@medtronic.com
+91 7045656069

Ryan Weispfenning
Medtronic Investor Relations
ryan.weispfenning@medtronic.com
+1-763-505-4626

Sakshi Tyagi
A.D.A.M. India
sakshi.tyagi@ebix.com
+91 9899938662